Administration of IL-6 in healthy individuals promotes fatigue and alters sleep structure [65], while IL-6 inhibitors in patients with rheumatoid arthritis reduce the level of fatigue, which precedes the anti-inflammatory effects on joint disease, suggesting a direct effect of IL-6 on the central nervous system [66]. This evidence concerns the gene IL6 and arthropathy.